Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$99 Sell
76
-82
-52% -$113 ﹤0.01% 4958
2026
Q1
$204 Buy
158
+86
+119% +$142 ﹤0.01% 4615
2025
Q4
$159 Buy
72
+52
+260% +$98 ﹤0.01% 4512
2025
Q3
$32 Buy
+20
New +$42 ﹤0.01% 4714
2025
Q2
Sell
-1
Closed -$4 4345
2025
Q1
$7 Hold
1
﹤0.01% 4253
2024
Q4
$7 Buy
+1
New +$7 ﹤0.01% 4549

Other funds holding LUNG

IFP Advisors's LUNG Position: Q2 2026 in Review

IFP Advisors reduced its Pulmonx (LUNG) stake by 52% in Q2 2026, selling an estimated $113 and leaving 76 shares worth $99. The position accounts for ﹤0.01% of the portfolio, ranked #4958.

IFP Advisors first reported a position in LUNG in Q4 2024 and has held it in 6 quarters since. The position peaked at $204 in Q1 2026. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • IFP Advisors held 76 shares of Pulmonx worth $99 as of Q2 2026.
  • IFP Advisors sold 82 Pulmonx shares in Q2 2026, an estimated $113.
  • Pulmonx made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4958 holding.
  • IFP Advisors first reported a position in Pulmonx in Q4 2024 and has held it in 6 quarters since.
  • IFP Advisors's Pulmonx position peaked at $204 in Q1 2026.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.